IMW 2019 | Off the shelf NK-cell MM therapy

Sarah Holstein

Sarah Holstein, MD, PhD, University of Nebraska Medical Center, Omaha, NE, elaborates on placental derived natural killer (NK) cells (PNK007) and their integration into the post-melphalan transplantation period of multiple myeloma (MM). Dr Holstein goes on to lay out the next steps for PNK-cell therapy. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video